211 related articles for article (PubMed ID: 18535099)
1. Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.
Smerdel-Ramoya A; Zanotti S; Stadmeyer L; Durant D; Canalis E
Endocrinology; 2008 Sep; 149(9):4374-81. PubMed ID: 18535099
[TBL] [Abstract][Full Text] [Related]
2. Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia.
Rydziel S; Stadmeyer L; Zanotti S; Durant D; Smerdel-Ramoya A; Canalis E
J Biol Chem; 2007 Jul; 282(27):19762-72. PubMed ID: 17500060
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice.
Canalis E; Zanotti S; Beamer WG; Economides AN; Smerdel-Ramoya A
Endocrinology; 2010 Aug; 151(8):3490-501. PubMed ID: 20534727
[TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells.
Luo Q; Kang Q; Si W; Jiang W; Park JK; Peng Y; Li X; Luu HH; Luo J; Montag AG; Haydon RC; He TC
J Biol Chem; 2004 Dec; 279(53):55958-68. PubMed ID: 15496414
[TBL] [Abstract][Full Text] [Related]
5. Skeletal overexpression of gremlin impairs bone formation and causes osteopenia.
Gazzerro E; Pereira RC; Jorgetti V; Olson S; Economides AN; Canalis E
Endocrinology; 2005 Feb; 146(2):655-65. PubMed ID: 15539560
[TBL] [Abstract][Full Text] [Related]
6. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
7. Notch inhibits osteoblast differentiation and causes osteopenia.
Zanotti S; Smerdel-Ramoya A; Stadmeyer L; Durant D; Radtke F; Canalis E
Endocrinology; 2008 Aug; 149(8):3890-9. PubMed ID: 18420737
[TBL] [Abstract][Full Text] [Related]
8. Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo.
Safadi FF; Xu J; Smock SL; Kanaan RA; Selim AH; Odgren PR; Marks SC; Owen TA; Popoff SN
J Cell Physiol; 2003 Jul; 196(1):51-62. PubMed ID: 12767040
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor enhances osteoblastogenesis in vitro.
Smerdel-Ramoya A; Zanotti S; Deregowski V; Canalis E
J Biol Chem; 2008 Aug; 283(33):22690-9. PubMed ID: 18583340
[TBL] [Abstract][Full Text] [Related]
10. Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation.
Xiao Z; Zhang S; Cao L; Qiu N; David V; Quarles LD
J Biol Chem; 2010 Jan; 285(2):1177-87. PubMed ID: 19887454
[TBL] [Abstract][Full Text] [Related]
11. Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis.
Canalis E; Smerdel-Ramoya A; Durant D; Economides AN; Beamer WG; Zanotti S
Endocrinology; 2010 Jan; 151(1):221-33. PubMed ID: 19934377
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of CCN genes in murine osteoblasts.
Parisi MS; Gazzerro E; Rydziel S; Canalis E
Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia.
Devlin RD; Du Z; Buccilli V; Jorgetti V; Canalis E
Endocrinology; 2002 Oct; 143(10):3955-62. PubMed ID: 12239107
[TBL] [Abstract][Full Text] [Related]
14. Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice.
Zanotti S; Canalis E
J Biol Chem; 2013 Jul; 288(30):21547-57. PubMed ID: 23782701
[TBL] [Abstract][Full Text] [Related]
15. Misexpression of CCAAT/enhancer binding protein beta causes osteopenia.
Zanotti S; Stadmeyer L; Smerdel-Ramoya A; Durant D; Canalis E
J Endocrinol; 2009 May; 201(2):263-74. PubMed ID: 19218285
[TBL] [Abstract][Full Text] [Related]
16. Nephroblastoma overexpressed (Nov) is a novel bone morphogenetic protein antagonist.
Canalis E
Ann N Y Acad Sci; 2007 Nov; 1116():50-8. PubMed ID: 18083920
[TBL] [Abstract][Full Text] [Related]
17. CTGF inhibits BMP-7 signaling in diabetic nephropathy.
Nguyen TQ; Roestenberg P; van Nieuwenhoven FA; Bovenschen N; Li Z; Xu L; Oliver N; Aten J; Joles JA; Vial C; Brandan E; Lyons KM; Goldschmeding R
J Am Soc Nephrol; 2008 Nov; 19(11):2098-107. PubMed ID: 18632843
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
19. Skeletal overexpression of noggin results in osteopenia and reduced bone formation.
Devlin RD; Du Z; Pereira RC; Kimble RB; Economides AN; Jorgetti V; Canalis E
Endocrinology; 2003 May; 144(5):1972-8. PubMed ID: 12697704
[TBL] [Abstract][Full Text] [Related]
20. Gremlin1 is required for skeletal development and postnatal skeletal homeostasis.
Canalis E; Parker K; Zanotti S
J Cell Physiol; 2012 Jan; 227(1):269-77. PubMed ID: 21412775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
